DEL ZINGARO, Michele
 Distribuzione geografica
Continente #
EU - Europa 16.381
NA - Nord America 9.227
AS - Asia 5.715
SA - Sud America 994
AF - Africa 179
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 7
Totale 32.522
Nazione #
IT - Italia 9.857
US - Stati Uniti d'America 9.021
SG - Singapore 2.521
UA - Ucraina 1.436
IE - Irlanda 976
SE - Svezia 920
RU - Federazione Russa 846
BR - Brasile 786
CN - Cina 780
HK - Hong Kong 696
VN - Vietnam 608
FR - Francia 510
DE - Germania 473
FI - Finlandia 351
KR - Corea 299
NL - Olanda 276
GB - Regno Unito 272
IN - India 147
BD - Bangladesh 141
TR - Turchia 123
CA - Canada 110
CH - Svizzera 89
PL - Polonia 87
AR - Argentina 81
BE - Belgio 60
MA - Marocco 59
PK - Pakistan 59
IQ - Iraq 53
MX - Messico 50
ES - Italia 47
CO - Colombia 40
ZA - Sudafrica 37
UZ - Uzbekistan 36
ID - Indonesia 35
JP - Giappone 35
RO - Romania 35
AT - Austria 29
EC - Ecuador 25
SA - Arabia Saudita 25
LB - Libano 20
CZ - Repubblica Ceca 19
TN - Tunisia 19
EG - Egitto 18
LT - Lituania 18
MY - Malesia 18
EU - Europa 16
VE - Venezuela 16
PH - Filippine 13
NP - Nepal 12
CL - Cile 11
IR - Iran 11
UY - Uruguay 11
GR - Grecia 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
CR - Costa Rica 9
PY - Paraguay 9
SM - San Marino 9
AL - Albania 8
DZ - Algeria 8
HU - Ungheria 8
IL - Israele 8
BO - Bolivia 7
KZ - Kazakistan 7
PT - Portogallo 7
AU - Australia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
KE - Kenya 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
JM - Giamaica 5
KG - Kirghizistan 5
OM - Oman 5
PE - Perù 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
ET - Etiopia 4
GE - Georgia 4
CI - Costa d'Avorio 3
DK - Danimarca 3
EE - Estonia 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
HR - Croazia 3
KH - Cambogia 3
LY - Libia 3
NI - Nicaragua 3
PA - Panama 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BZ - Belize 2
Totale 32.471
Città #
Singapore 1.735
Chandler 1.362
Milan 1.127
Dublin 969
Jacksonville 698
Hong Kong 690
San Jose 613
San Mateo 597
Rome 559
Ashburn 503
Boardman 387
Dong Ket 312
Santa Clara 301
Seoul 299
Florence 277
Moscow 259
Turin 255
Perugia 254
Medford 252
Princeton 249
Lauterbourg 212
Wilmington 192
Naples 177
Ann Arbor 172
Des Moines 158
Beijing 147
Andover 144
Munich 125
Altamura 119
Los Angeles 117
Piscataway 117
New York 109
Ho Chi Minh City 106
Lawrence 90
Bologna 83
Genoa 79
Shanghai 77
Helsinki 76
Saint Petersburg 71
The Dalles 67
Brescia 65
Izmir 62
Hanoi 60
Redwood City 60
Orem 59
Verona 59
São Paulo 57
Brussels 56
Palermo 51
Dallas 48
Turku 47
Norwalk 45
Ottawa 43
Bari 42
Woodbridge 42
Pescara 41
Torino 40
Bergamo 39
Ouezzane 38
Chennai 37
Warsaw 37
Napoli 36
Brooklyn 35
Frankfurt am Main 35
Catania 34
Chicago 34
Council Bluffs 33
Stockholm 33
Tokyo 32
Como 31
Monza 31
Redmond 30
Padova 28
Atlanta 26
Baghdad 26
Columbus 26
Falls Church 26
Cagliari 25
Montreal 25
Parma 25
Rio de Janeiro 25
Tashkent 24
Johannesburg 23
Paris 23
Houston 22
Mumbai 22
Scandiano 22
London 21
Manchester 21
Belo Horizonte 20
Denver 20
Lucca 20
Amsterdam 19
Bucharest 19
Caserta 19
Livorno 19
Modena 19
Reggio Emilia 19
Nuremberg 18
Philadelphia 18
Totale 16.148
Nome #
Il ruolo della TURB II-Look nei tumori superficiali della vescica: revisione sistematica della letteratura e meta-analisi 7.709
BCG vs Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio. Studio prospettico randomizzato. 1.752
Ruolo della colposospensione sec.Burch associata a ricostruzione integrale per via addominale in pazienti continenti e incontinenti affette da prolasso urogenitale avanzato. Rivalutazione a lungo termine di 2 studi clinici randomizzati 416
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 409
Ruolo dell’ecografia nella valutazione delle complicanze della chirurgia pelvica con impiego di protesi 276
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 264
La correzione del prolasso urogenitale mediante la colposacropessia e la isterocolposacropessia 247
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 240
Abdominal surgery for uterovaginal prolapse: sacropexy vs hysterocolposacropexy 168
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 167
SLING MEDIOURETRALE RETROPUBICA E TRANSOTTURATORIA A CONFRONTO NELLE PAZIENTI CON INCONTINENZA URINARIA MISTA NON RESPONSIVA A TERAPIA CONSERVATIVA 162
Renal Artery Embolization Before Radical Nephrectomy for Complex Renal Tumour: Which are the True Advantages? 149
Abdominal integral pelvic reconstruction plus or minus Burch colposuspension in the treatment of severe uro-genital prolapse associated to urinary incontinence. A RCT with a mid-term follow up 140
Abdominal pelvic floor reconstruction with uterus preservation 140
Performance of incontinence impact questionnaire (IIQ) in italian population according to educational status 140
A personal surgical experience with orthotopic ileal neo-bladder reconstruction: long term functional results 139
Effects of Botulinum-A toxin intravesical injections on bladder hypersensitive disorders: a pilot study 133
Holmium:YAG Laser for the Treatment of Genital and urethral Warts: Multicentre Prospective Evaluation of Safety and Efficacy 129
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair? A case control study 127
Long-term outcome of anti-incontinence procedure during Pelvic Organ Prolapse repair in patients with or without urinary incontinence: results from two randomized surgical trials 126
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 126
Fournier's gangrene secondary to locally advanced prostate cancer: case report and review of the Literature 125
Prulifloxacin vs Phosphomycin: Prophylaxis in patients with recurrent UTI. Preliminary results of a randomized multi-centre study 124
Colovesical fistula: review on conservative management, surgical techniques and minimally invasive approaches 124
Influence of COVID-19 pandemic on stress levels of urologic patients 123
Anastomosi microchirurgiche e studio eco-color-Doppler 122
Risultati chirurgici nelle donne in età avanzata 122
Advanced Urodynamic methods in the diagnosis of bladder outlet obstruction in females 121
Comparing PUMA with other advanced urodynamic methods in the diagnosis of bladder outlet obstruction in men with benign prostatic hypertrophy 121
Il Q-tip test vs ecografia nella diagnosi di ipermobilità uretrale: nostra esperienza 121
Leiomioma mixoide vaginale parauretrale 120
Fournier's Gangrene and Intravenous Drug Abuse: an Unusual Case Report and Review of The Literature 120
Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial 120
Valutazione ecografica del deficit sfinterico uretrale: nostra esperienza 118
Uterus preservation vs hysterectomy during sacropexy 118
Valsalva Leak Point pressure e successo della uretropessi retropubica nelle pazienti affette da severo prolasso urogenitale. Dati preliminari 117
Affidabilità dell'ecografia nella diagnosi dell'ipermobilità uretrale: dati preliminari 117
Test-retest of Valsalva leak point pressure 116
Safety and efficacy of a modified technique of holmium laser enucleation of the prostate (Holep) for benign prostatic hyperplasia 116
Body mass Index and urinary symptoms in women 115
Management of healing abnormalities after abdominal pelvic organ prolapse repair 114
Determinazione dei livelli vescicali tissutali di isoprostano 8-epi-PGF2 alfa in pazienti con disfunzioni vescico-sfinteriche ad elevato stress ossidativo 114
New evolution of robotic radical prostatectomy: A single center experience with PERUSIA technique 114
La colposospensione associata a Ricostruzione integrale del pavimento pelvico. 114
Botulinum a toxin intravesical injections for painful bladder syndrome: impact upon pain, psychological functioning and quality of life 113
Sacropexy with uterine conservation: results after 5 years 113
Diagnosi ecografica di iperattività detrusoriale: nostra esperienza 112
Prospettiva di impiego della RMN nel follow-up dell’operato di amputazione addomino-perineale per carcinomale rettale 112
.“Semeiotica urologica” Manuale di Chirurgia Monduzzi Editore 111
Long-Term follow-up uterus sparing surgery for pelvic organ prolapse (POP) 111
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 110
POLYVINYLIDENFLUORID (PVDF) AND POLYPROPYLENE MESH FOR SACROCOLPOPEXY: A COMPARATIVE STUDY 110
Evaluation of Surgical Site Infection in Mini-invasive Urological Surgery 110
A PROSPECTIVE RANDOMIZED TRIAL: ABDOMINAL VS LAPAROSCOPIC SACROPEXY FOR ADVANCED PELVIC ORGAN PROLAPSE 109
Early recovery of pre-RARP latency time in uroflow stop test with EMG may predict early erectile function restoration 109
Ruolo dell’ESWL nella terapia della litiasi complessaCongresso Nazionale SIU 108
Disobstruction after RARP in low-risk prostate cancer: a case-control study 108
Bladder and urethral sphincter function after radical retropubic prostectomy: 3 years follow up. 107
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 107
Iniezione intravescicale di tossina botulinica A nel trattamento della vescica ipersensibile 107
Somministrazione intradetrusoriale di tossina botulinica A in pazienti con iperattività detrusoriale e vescica iperattiva dovute a M. di Parkinson ed Atrofia Multisistemica 107
Bladder outlet obstruction in men with benign prostatic hypertrophy 107
UROLOGIC LATENCY TIME (ULT) DURING UROFLOW STOP TEST WITH ELECTROMYOGRAPHY: A POST-RARP CONTINENCE DETECTOR 106
Is Valsalva Leak point pressure a reliable test? 105
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 105
La colposospensione associata a ricostruzione integrale del pavimento pelvico 104
VALUTAZIONE ECOGRAFICA DELLE PAZIENTI SOTTOPOSTE AD INTERVENTO DI CORREZZIONE DELLA STATICA PELVICA CON IMPIEGO DI PROTESI 104
ESWL in Renal Stone Clearance from Calyxes 104
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 104
Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: Case report and review of the literature 104
Affidabilità dell’ecografia nella diagnosi dell’ipermobilità uretrale: dati preliminari 103
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 103
Role of miRNAs in prostate cancer: Do we really know everything? 103
Ruolo della re-turb nei tumori vesciali superficiali ad altro rischio di progressione e recidiva. 102
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 102
Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma 101
Preservazione dell'utero o isterectomia negli interventi di sacropessia per prolasso uterovaginale: due tecniche a confronto 100
Chirurgia del prolasso con preservazione dell’utero: risultati a lungo termine 100
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy 100
Profilassi con Plurifloxacina vs Fosfomicina in pawienti affette da cistiti ricorrenti. Risultati preliminari di uno studio randomizzato 98
Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: A randomized surgical trial 98
ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL 98
Il q-tip test nella diagnosi di ipermobilità uretrale 98
Surgical outcome during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair: case control study 97
Female sexual function evaluation in patients who underwent integral pelvic floor reconstructive surgery 97
Isterocolposacropessia:confronto tra videolaparoscopia e chirurgia open 97
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent POP (Pelvic Organ Prolapse) repair 97
Echo-color doppler in the diagnosis of vascular abnormalities associated with ureteropelvic junction obstruction 96
The management of pelvic organ prolapse. A review 96
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 96
Trattamento endovescicale adiuvante del TCC superficiale ad alto rischio con mitomicina elettroindotta vs BCG. 96
Traumi della milza : nostra esperienza 96
Pre and post-operative urodynamic patterns and continence in patients undergoing bladder-neck- sparing radical retro-pubic prostatectomy (RRP) 95
Relationships between voiding dysfunction and peripheral neuropathy in asymptomatic patients affected by diabetes mellitus type I: preliminary results. 94
Recurvatum congeniti ed acquisiti del pene 94
Mini-invasive techniques for the treatment of female stress urinary incontinence 94
Enhanced patient recovery with early extensive surgical deb-ridement in Fournier's Gangrene: evaluation of perioperative outcomes in a multicentric experience 93
Ricostruzione integrale del pavimento pelvico 93
TRATTAMENTO ENDOVESCICALE ADIUVENTE DEL TCC SUPERFICIALE AD ALTO RISCHIO CON MITOMICINA ELETTROINDOTTA VS BCG: NOSTRA ESPERIENZA 93
Valutazione ecografica delle pazienti sottoposte ad intervento di correzione della statica pelvica con impiego di protesi 93
Totale 21.625
Categoria #
all - tutte 107.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.058 86 579 130 241 142 68 84 642 81 93 394 518
2022/20235.330 412 598 242 359 400 584 173 406 1.469 139 331 217
2023/20243.019 228 287 194 202 134 105 438 265 305 175 370 316
2024/20255.220 218 495 260 287 655 270 269 447 818 372 666 463
2025/20268.272 658 619 495 1.022 935 668 1.180 447 914 804 298 232
2026/2027160 160 0 0 0 0 0 0 0 0 0 0 0
Totale 32.974